| Name | ethyl (5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-5-hydroxy-3-oxohept-6-enoate |
|---|---|
| Synonyms |
3-keto-5-hydroxy rosuvastatin ethyl ester
(S,E)-Ethyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-5-hydroxy-3-oxoht-6-enoate (5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-3-oxo-6-heptenoic acid ethyl ester ethyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-3-oxo-(5S)-5-hydroxy-(6E)-heptenoate (5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-3-oxo-6-htenoic acid ethyl ester Bicteavir Impurity 16 (S,E)-Ethyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-5-hydroxy-3-oxohept-6-enoate ethyl 6-(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[N-methyl-N-methylsulfonylamino]pyrimidin-5-yl]-(5S)-hydroxy-3-oxoheptenoate 3-Ketorosuvastatin Ethyl Ester (S,E)-Ethyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-5-h 3-keto-5-hydroxy-ethyl rosuvastatin (5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-Methylethyl)-2-[Methyl(Methylsulfonyl)amino]-5-pyriMidinyl]-5-hyd ethyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-3-oxo-5(S)-hydroxy-6(E)-heptenoate (S)-trans-ethyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-5-hydroxy-3-oxohept-6-enoate (S,E)-Ethyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido) pyrimidin-5-yl)-5-hyd 6-Htenoic acid,7-[4-(4-fluorophenyl)-6-(1-Methylethyl)-2-[Methyl(Methylsulfonyl)amino]-5-pyriMidinyl]-5-hydroxy-3-oxo-, ethyl ester, (5S,6E) |
| Molecular Formula | C24H30FN3O6S |
|---|---|
| Molecular Weight | 507.57500 |
| Exact Mass | 507.18400 |
| PSA | 135.14000 |
| LogP | 4.16920 |
|
~88%
901765-36-4 |
| Literature: ASTRAZENECA UK LIMITED Patent: WO2007/7119 A1, 2007 ; Location in patent: Page/Page column 20 ; WO 2007/007119 A1 |
|
~92%
901765-36-4 |
| Literature: ASTRAZENECA UK LIMITED Patent: WO2008/65410 A1, 2008 ; Location in patent: Page/Page column 27 ; WO 2008/065410 A1 |
|
~64%
901765-36-4 |
| Literature: AUROBINDO PHARMA LIMITED Patent: WO2008/96257 A1, 2008 ; Location in patent: Page/Page column 21-24 ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |